Trial · NCT07881627
Nutritional Status in Patients With Chronic Kidney Disease Receiving 7.2% Amino Acids During Hemodialysis
NCT07881627, Recruiting, PT Otsuka Indonesia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Nutritional Status in Patients With Chronic Kidney Disease Receiving 7.2% Amino Acids During Hemodialysis. Trials, record NCT07881627. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881627
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Nutritional Status in Patients With Chronic Kidney Disease Receiving 7.2% Amino Acids During Hemodialysis
- NCT number
- NCT07881627
- Status
- Recruiting
- Enrollment
- 90 participants, estimated
- Lead sponsor
- PT Otsuka Indonesia
- Conditions
- Malnutitrion, Chronic Kidney Disease on Hemodialysis, Anemia (Diagnosis)
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Serum Albumin Level from Baseline to Month 3 | Baseline to month 3 | Serum albumin will be measured in grams per deciliter (g/dL). The change will be calculated as the serum albumin level at Month 3 minus the serum albumin level at baseline. The change will be compared between patients who received intradialytic parenteral nutrition (IDPN) and patients who did not receive IDPN. |
| Secondary | Serum Albumin Level at Follow-up | Month 3 and end of study (Months 3-6 | Serum albumin levels (g/dL) at follow-up, compared between IDPN and control groups. |
| Secondary | Change in Serum Albumin From Baseline | Baseline to end of study (Months 3-6) | Change in serum albumin (g/dL), calculated as end-of-study minus baseline, compared between groups. |
| Secondary | Hemoglobin Level at Each Assessment | Baseline; Months 1, 2, 3; end of study (Months 3-6) | Hemoglobin levels (g/dL) at scheduled assessments, compared between IDPN and control groups. |
| Secondary | Change in Hemoglobin From Baseline | Baseline to Months 1, 2, 3 and end of study (Months 3-6) | Change in hemoglobin (g/dL), calculated as follow-up minus baseline, compared between groups. |
| Secondary | Change in Nutritional Status Assessed by SGA | Baseline to end of study (Months 3-6) | 7-point SGA assessment at baseline and end of study, compared between IDPN and control groups. |
| Secondary | Change in Quality of Life Assessed by KDQOL-36 | Baseline to end of study (Months 3-6) | KDQOL-36 score assessment at baseline and end of study, compared between IDPN and control groups. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07881627
GET https://conductscience.org/api/trials/v1/NCT07881627/registered